Table 2.

Associations between miRNAs and clinicopathological features studied in current meta-analysis

Clinicopathological features	miRNAs	Figures
Presence of metastasis
GM	miR-410-3p, miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p, miR-301a, miR-503, miR-543	Figure 2a
LNM	miR-802, miR-301a, miR-503	Figure 2b
DM	miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p	Figure 2c
BM	miR-141-3p, miR-210-3p	Figure 2d
Total Gleasone scor
GS > 6	miR-410-3p, miR-132, miR-212, miR-203, miR-409-3p, miR-409-5p, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a	Figure 2e
GS > 7	miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p, miR-203, miR-409-3p, miR-409-5p, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a	Figure 2f
pT stage according to TNM	miR-410-3p, miR-132, miR-212, miR-802, miR-203, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a	Figure 2g

GM general metastasis, LNM lymph node metastasis, DM distant metastasis, BM bone metastasis, GS Gleason score, pT stage-pathological tumor stage